Review ArticleREVIEWS AND CONTEMPORARY UPDATES
Open Access

Directed Donation: Special Considerations and Review for Contemporary Clinical Practices

Gordon Wadge, Jenny Zhang, John Seal, Edgar Shannon Cooper and Caroline R. Alquist
Ochsner Journal September 2021, 21 (3) 281-286; DOI: https://doi.org/10.31486/toj.20.0068

REFERENCES

  1. 1.↵
    1. Blundell J
    . Some account of a case of obstinate vomiting, in which an attempt was made to prolong life by injection of blood into the veins. Med Chir Trans. 1819;10(Pt 2):295-311.
    OpenUrl
  2. 2.↵
    WHO Expert Group. Expert consensus statement on achieving self-sufficiency in safe blood and blood products, based on voluntary non-remunerated blood donation (VNRBD). Vox Sang. 2012;103(4):337-342. doi: 10.1111/j.1423-0410.2012.01630.x
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Klein HG,
    2. McCurdy PR,
    3. Nemo G,
    4. Rogus SD,
    5. Sloand E,
    6. Fink BJ
    ; National Heart, Lung, and Blood Institute Expert Panel on the use of Autologous Blood. Transfusion alert: use of autologous blood. Transfusion. 1995;35(8):703-711. doi: 10.1046/j.1537-2995.1995.35895357904.x
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    1. Titmuss RM
    . The Gift Relationship: From Human Blood to Social Policy. Geroge Allen and Unwin; 1970.
  5. 5.↵
    1. Rapport FL,
    2. Maggs CJ
    . Titmuss and the gift relationship: altruism revisited. J Adv Nurs. 2002;40(5):495-503. doi: 10.1046/j.1365-2648.2002.02406.x
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Fridey JL,
    2. Townsend MJ,
    3. Kessler DA,
    4. Gregory KR
    . A question of clarity: redesigning the American Association of Blood Banks blood donor history questionnaire–a chronology and model for donor screening. Transfus Med Rev. 2007;21(3):181-204. doi: 10.1016/j.tmrv.2007.03.001
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Hughes S,
    2. Sheon N,
    3. Siedle-Khan B,
    4. Custer B
    . Saving lives, maintaining safety, and science-based policy: qualitative interview findings from the Blood Donation Rules Opinion Study (Blood DROPS). Transfusion. 2015;55(12):2835-2841. doi: 10.1111/trf.13268
    OpenUrlCrossRef
  8. 8.↵
    1. Grenfell P,
    2. Nutland W,
    3. McManus S,
    4. Datta J,
    5. Soldan K,
    6. Wellings K
    . Views and experiences of men who have sex with men on the ban on blood donation: a cross sectional survey with qualitative interviews. BMJ. 2011;343:d5604. doi: 10.1136/bmj.d5604
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Busch MP,
    2. Bloch EM,
    3. Kleinman S
    . Prevention of transfusion-transmitted infections. Blood. 2019;133(17):1854-1864. doi: 10.1182/blood-2018-11-833996
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Franchini M,
    2. Mannucci PM
    . Past, present and future of hemophilia: a narrative review. Orphanet J Rare Dis. 2012;7:24. doi: 10.1186/1750-1172-7-24
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Goedert JJ,
    2. Sarngadharan MG,
    3. Eyster ME,
    4. et al.
    Antibodies reactive with human T cell leukemia viruses in the serum of hemophiliacs receiving factor VIII concentrate. Blood. 1985;65(2):492-495.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Rosendaal FR,
    2. Smit C,
    3. Briët E
    . Hemophilia treatment in historical perspective: a review of medical and social developments. Ann Hematol. 1991;62(1):5-15. doi: 10.1007/bf01714977
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Fletcher ML,
    2. Trowell JM,
    3. Craske J,
    4. Pavier K,
    5. Rizza CR
    . Non-A non-B hepatitis after transfusion of factor VIII in infrequently treated patients. Br Med J (Clin Res Ed). 1983;287(6407):1754-1757. doi: 10.1136/bmj.287.6407.1754
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Federici AB,
    2. Berntorp E,
    3. Lee CA
    . The 80th anniversary of von Willebrand's disease: history, management and research. Haemophilia. 2006;12(6):563-572. doi: 10.1111/j.1365-2516.2006.01393.x
    OpenUrlCrossRefPubMedWeb of Science
  15. 15.↵
    1. Federici AB,
    2. Santagostino E,
    3. Rumi MG,
    4. et al.
    The natural history of hepatitis C virus infection in Italian patients with von Willebrand's disease: a cohort study. Haematologica. 2006;91(4):503-508.
    OpenUrlAbstract/FREE Full Text
  16. 16.↵
    1. Sharma R,
    2. Flood VH
    . Advances in the diagnosis and treatment of Von Willebrand disease. Blood. 2017;130(22):2386-2391. doi: 10.1182/blood-2017-05-782029
    OpenUrlAbstract/FREE Full Text
  17. 17.↵
    1. Mannucci PM
    . Treatment of von Willebrand's disease. N Engl J Med. 2004;12;351(7):683-694. doi: 10.1056/NEJMra040403
    OpenUrlCrossRef
  18. 18.↵
    1. Dorsey KA,
    2. Moritz ED,
    3. Steele WR,
    4. Eder AF,
    5. Stramer SL
    . A comparison of human immunodeficiency virus, hepatitis C virus, hepatitis B virus, and human T-lymphotropic virus marker rates for directed versus volunteer blood donations to the American Red Cross during 2005 to 2010. Transfusion. 2013;53(6):1250-1256. doi: 10.1111/j.1537-2995.2012.03904.x
    OpenUrlCrossRef
  19. 19.↵
    1. Stramer SL,
    2. Notari EP,
    3. Krysztof DE,
    4. Dodd RY
    . Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety? Transfusion. 2013;53(10 Pt 2):2449-2458. doi: 10.1111/trf.12213
    OpenUrlCrossRef
  20. 20.↵
    1. Zou S,
    2. Stramer SL,
    3. Dodd RY
    . Donor testing and risk: current prevalence, incidence, and residual risk of transfusion-transmissible agents in US allogeneic donations. Transfus Med Rev. 2012;26(2):119-128. doi: 10.1016/j.tmrv.2011.07.007
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Jacquot C,
    2. Seo A,
    3. Miller PM,
    4. et al.
    Parental versus non-parental–directed donation: an 11-year experience of infectious disease testing at a pediatric tertiary care blood donor center. Transfusion. 2017;57(11):2799-2803. doi: 10.1111/trf.14312
    OpenUrlCrossRef
  22. 22.↵
    1. Schonewille H,
    2. Haak HL,
    3. van Zijl AM
    . Alloimmunization after blood transfusion in patients with hematologic and oncologic diseases. Transfusion. 1999;39(7):763-771. doi: 10.1046/j.1537-2995.1999.39070763.x
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Hiruma K,
    2. Okuyama Y
    . Effect of leucocyte reduction on the potential alloimmunogenicity of leucocytes in fresh-frozen plasma products. Vox Sang. 2001;80(1):51-56. doi: 10.1046/j.1423-0410.2001.00011.x
    OpenUrlCrossRefPubMed
  24. 24.↵
    Trial to Reduce Alloimmunization to Platelets Study Group. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. N Engl J Med. 1997;337(26):1861-1869. doi: 10.1056/NEJM199712253372601
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.↵
    1. Lerut E,
    2. Van Damme B,
    3. Noizat-Pirenne F,
    4. et al.
    Duffy and Kidd blood group antigens: minor histocompatibility antigens involved in renal allograft rejection? Transfusion. 2007;47(1):28-40. doi: 10.1111/j.1537-2995.2007.01060.x
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.
    1. Au WY,
    2. Liu CL,
    3. Lo CM,
    4. Fan ST,
    5. Lam MF,
    6. Lam CK.
    Red blood cell alloantibodies and liver transplantation in Chinese patients. Transplantation. 2003;75(11):1904-1906. doi: 10.1097/01.TP.0000065741.31599.9C
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. Makroo RN,
    2. Agrawal S,
    3. Chowdhry M,
    4. Bhatia A,
    5. Thakur UK
    . Red cell alloimmunization & role of advanced immunohaematological support in liver transplantation. Indian J Med Res. 2017;145(4):488-491.
    OpenUrl
  28. 28.↵
    1. Schroeder ML
    . Transfusion-associated graft-versus-host disease. Br J Haematol. 2002;117(2):275-287. doi: 10.1046/j.1365-2141.2002.03450.x
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Shimoda T
    . On postoperative erythroderma. Surgery. Article in Japanese. 1955;17:487-492. (in Japanese).
    OpenUrl
  30. 30.↵
    1. Wylie B
    . Which methods of donor recruitment give the safest donors? Malays J Pathol. 1993;15(2):99-103.
    OpenUrlPubMed
  31. 31.↵
    1. Chaffin J
    . Blood Bank Guy Essentials Podcast. 062CE: Autologous and Directed Donation with Julie Karp. January 18, 2019. Accessed February 4, 2021. bbguy.org/2019/01/18/062
  32. 32.↵
    1. Flickinger C,
    2. Petrone T,
    3. Church A
    . Review: American rare donor program. Immunohematology. 2004;20(4):239-243.
    OpenUrl
  33. 33.↵
    1. Dipta TF,
    2. Hossain AZ
    . The Bombay blood group: are we out of risk? Mymensingh Med J. 2011;20(3):536-540.
    OpenUrlPubMed
  34. 34.↵
    1. Flickinger C
    . In search of red blood cells for alloimmunized patients with sickle cell disease. Immunohematology. 2006;22(3):136-142.
    OpenUrl
  35. 35.↵
    1. Yazdanbakhsh K,
    2. Ware RE,
    3. Noizat-Pirenne F
    . Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management. Blood. 2019;120(3):528-537. doi: 10.1182/blood-2011-11-327361
    OpenUrlCrossRef
  36. 36.↵
    1. Nelson KA,
    2. Aldea GS,
    3. Warner P,
    4. et al.
    Transfusion-related immunomodulation: gamma irradiation alters the effects of leukoreduction on alloimmunization. Transfusion. 2019;59(11):3396-3404. doi: 10.1111/trf.15555
    OpenUrlCrossRef
  37. 37.↵
    1. Hod E,
    2. Schwartz J.
    Platelet transfusion refractoriness. Br J Haematol. 2008;142(3):348-360. doi: 10.1111/j.1365-2141.2008.07189.x
    OpenUrlCrossRefPubMed
  38. 38.↵
    1. Pavenski K,
    2. Freedman J,
    3. Semple JW
    . HLA alloimmunization against platelet transfusions: pathophysiology, significance, prevention and management. Tissue Antigens. 2012;79(4):237-245. doi: 10.1111/j.1399-0039.2012.01852.x
    OpenUrlCrossRefPubMed
  39. 39.↵
    1. West KA,
    2. Conry-Cantilena C
    . Granulocyte transfusions: current science and perspectives. Semin Hematol. 2019;56(4):241-247. doi: 10.1053/j.seminhematol.2019.11.002
    OpenUrlCrossRef
  40. 40.↵
    1. Gea-Banacloche J
    . Granulocyte transfusions: a concise review for practitioners. Cytotherapy. 2017;19(11):1256-1269. doi: 10.1016/j.jcyt.2017.08.012
    OpenUrlCrossRef
  41. 41.↵
    1. Hübel K,
    2. Carter RA,
    3. Liles WC,
    4. et al.
    Granulocyte transfusion therapy for infections in candidates and recipients of HPC transplantation: a comparative analysis of feasibility and outcome for community donors versus related donors. Transfusion. 2002;42(11):1414-1421. doi: 10.1046/j.1537-2995.2002.00249.x
    OpenUrlCrossRefPubMed
  42. 42.↵
    1. Massey E,
    2. Harding K,
    3. Kahan BC,
    4. et al.
    The granulocytes in neutropenia 1 (GIN 1) study: a safety study of granulocytes collected from whole blood and stored in additive solution and plasma. Transfus Med. 2012;22(4):277-284. doi: 10.1111/j.1365-3148.2012.01152.x
    OpenUrlCrossRefPubMed
  43. 43.↵
    1. Price TH,
    2. Boeckh M,
    3. Harrison RW,
    4. et al.
    Efficacy of transfusion with granulocytes from G-CSF/dexamethasone–treated donors in neutropenic patients with infection. Blood. 2015;126(18):2153-2161. doi: 10.1182/blood-2015-05-645986
    OpenUrlAbstract/FREE Full Text
  44. 44.↵
    1. Winkelhorst D,
    2. Oepkes D,
    3. Lopriore E
    . Fetal and neonatal alloimmune thrombocytopenia: evidence based antenatal and postnatal management strategies. Expert Rev Hematol. 2017;10(8):729-737. doi: 10.1080/17474086.2017.1346471
    OpenUrlCrossRef
  45. 45.
    1. Reznikoff-Etievant MF
    . Management of alloimmune neonatal and antenatal thrombocytopenia. Vox Sang. 1988;55(4):193-201. doi: 10.1111/j.1423-0410.1988.tb04697.x
    OpenUrlCrossRefPubMedWeb of Science
  46. 46.↵
    1. Daffos F,
    2. Capella-Pavlovsky M,
    3. Forestier F
    . Fetal blood sampling via the umbilical cord using a needle guided by ultrasound. Report of 66 cases. Prenat Diagn. 1983;3(4):271-277. doi: 10.1002/pd.1970030402
    OpenUrlCrossRefPubMedWeb of Science
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools

Jump to section

Keywords